SEC Form 4 · accession 0001415889-15-002218
INNOVUS PHARMACEUTICALS, INC. · INNV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bassam Damaj
Officer — PRESIDENT AND CEO · Director · 10% Owner
Period of report
Jun 26, 2015
Accepted (ET)
Jun 29, 2015 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 26, 2015 | A | 50 | $0.1167 | A | 6,852,322 | D |
Table II — derivative securities
No Table II lines on this filing.